Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.
Vitória Berg CattaniEmilia Moreira JalilLeonardo EkstermanThiago Silva TorresSandra Wagner CardosoCristiane R V CastroLaylla MonteiroErin C WilsonLane BushmanPeter L AndersonValdilea Gonçalves VelosoBeatriz Gilda Jegerhorn GrinsztejnRita Estrelanull nullPublished in: Clinical pharmacokinetics (2023)
This trial (NCT03220152) was registered on July 18, 2017.
Keyphrases
- hiv testing
- men who have sex with men
- antiretroviral therapy
- hiv positive
- polycystic ovary syndrome
- hiv infected
- human immunodeficiency virus
- study protocol
- phase iii
- hepatitis c virus
- hiv aids
- clinical trial
- phase ii
- pregnancy outcomes
- cervical cancer screening
- estrogen receptor
- human health
- south africa
- pregnant women
- skeletal muscle
- insulin resistance
- metabolic syndrome
- risk assessment
- type diabetes
- open label
- placebo controlled